Thomas Scott Carter

Med tech market development - Technology + Education can change patient outcomes. Views own.

[SGRT Community @SGRTCommunity]

At the US SGRT Community Meeting, Kiran Kumar, MD, shared how non-coplanar treatments are showing exciting clinical benefits for lymphoma, breast, and head & neck cancers - including significant dose reduction to OARs.

#SGRTUS25

[Thomas Scott Carter @ThomasSCarter]

@SGRTCommunity Interested in #reirradiation? Tune in...

[SGRT Community @SGRTCommunity]

Join us for this month's SGRTuesdays session to explore the latest evidence in surface-guided planning.

Hear how MapRT is delivering real benefits like:
• Time savings
• Improved plan safety
• Greater clinical confidence

Register here: https://t.co/52tp9Nr2Cl

[Vision RT @VisionRTLtd]

Register now for a FREE event combining clinical presentations with the chance to attend an in-person site visit at a center using SGRT across their entire workflow!

Learn more: https://t.co/oDDH83I5fp

[Drew Moghanaki @DrewMoghanaki]

A new medical oncology position has opened at the VA Medical Center in Long Beach. Please share so we can recruit optimal candidates: https://t.co/mMu6fHePB6

[Drew Moghanaki @DrewMoghanaki]

SBRT helps avoid SYSTEMIC THERAPY INTENSIFICATION in 50% of patients with stage IV cancer without any serious side effects in 99%.

Name a single drug that can accomplish this. I’ll wait…. @jillfeldman4

[Drew Moghanaki @DrewMoghanaki]

The VA in Minneapolis is hiring a full-time dosimetrist.

With federal benefits!

The job posting is through January 21, 2025. Please share 📷https://t.co/zz2cYwIfcc

[Thomas Scott Carter @ThomasSCarter]

@NerdyJennzy What did you move on to Dr B?

(By the way, I’ve been looking at your work on dynamic trajectory planning and wondered if you had considered MapRT for patient-specific clearance mapping? We just got CE mark)

[Vision RT @VisionRTLtd]

Exciting Research in Radiotherapy!

Help Clinical Scientist in Radiotherapy Physics, Priscila Páez, gain insights into the current use of this approach by completing this short survey.

Take the survey: https://t.co/hdJSCKMPcE

#NonCoplanar #RadiationOncology
#RadiationTherapy

[SGRT Community @SGRTCommunity]

We're pleased to announce early registration is open for the Annual European Meeting of the SGRT Community! This year’s theme: Game Changer.

Plus, there’s still time to submit an abstracts & showcase your expertise!

Be a part of our biggest event yet: https://t.co/Rgi7gCKlky

[Vision RT @VisionRTLtd]

As #WorldHeadAndNeckCancerDay approaches, Vision RT is proud to highlight the incredible work being done at Lincoln County Hospital to make treatments more comfortable and accurate for patients.

[Thomas Scott Carter @ThomasSCarter]

@NerdyJennzy @RadiotherapyOn1 @OncoAlert @inselgruppe @unibern You might be interested in this, in pre-print. Evidence not only that noncoplanar can give better plans but also that experienced planners can miss opportunities without a patient-specific clearance map https://t.co/Xg8YvOlQ3x

[Vision RT @VisionRTLtd]

Congratulations to the team at @DanaFarber, Massachusetts for going tattoo & mark-free!

Thanks to AlignRT, they can now eliminate the need for radiotherapy tattoos, while delivering accurate patient setup and monitoring.

Learn more: https://t.co/lv3GkxVq7d

[Vision RT @VisionRTLtd]

Our latest case study with Florida Cancer Specialists shows a 50% reduction in setup time and re-imaging rates thanks to AlignRT. This means:

- Faster, more comfortable treatments for patients
- Increased efficiency for the clinic

Learn more: https://t.co/peqw8uVlzl

[Thomas Scott Carter @ThomasSCarter]

@aitchemcee283 There are a bunch of people you haven’t failed Helen! 💐

[Vision RT @VisionRTLtd]

Dr. Med. Benjamin Gauter-Fleckenstein from Darmstadt Germany on using MapRT for non-coplanar treatments:

[Thomas Scott Carter @ThomasSCarter]

@VisionRTLtd This is a great summary of what clearance mapping can bring to #radonc patients.

[Thomas Scott Carter @ThomasSCarter]

@cancerphysicist @VisionRTLtd @bsc_urology @GEHealthCare I think you can target the Green Journal. 😂

[Thomas Scott Carter @ThomasSCarter]

@cancerphysicist Ane, thank you for raising the profile of this important conversation in European radiation oncology 😀 While I have to declare an interest (see my profile), @VisionRTLtd @bsc_urology and @GEHealthCare should ensure we maximise the number of trial subjects with complete datasets.